Evidence map›Paper›PMID 26466580›Full record

ArticleSubstance abuse treatment, prevention, and policy2015

Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users.

Andrea Petróczi, Jorge A Vela Ocampo, Iltaf Shah, Carl Jenkinson, Rachael New, Ricky A James, Glenn Taylor, Declan P Naughton

Abstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Targeting Energy Expenditure-Drugs for Obesity Treatment.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017
    Article
  17. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2016
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea PetrócziFaculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames, Surrey, KT1 2EE, United Kingdom. A.Petroczi@kingston.ac.uk.
Jorge A Vela OcampoFaculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames, Surrey, KT1 2EE, United Kingdom. k1230202@kingston.ac.uk.
Iltaf ShahFaculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames, Surrey, KT1 2EE, United Kingdom. iltafsyed@hotmail.com.
Carl JenkinsonUniversity of Birmingham, Birmingham, UK. C.Jenkinson@bham.ac.uk.
Rachael NewHampshire County Council-Scientific Services, Hampshire, UK. rachael.new@hants.gov.uk.
Ricky A JamesFaculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames, Surrey, KT1 2EE, United Kingdom. Ricky.James@kingston.ac.uk.
Glenn TaylorHampshire County Council-Scientific Services, Hampshire, UK. grjtaylor@icloud.com.
Declan P NaughtonFaculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames, Surrey, KT1 2EE, United Kingdom. D.Naughton@kingston.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background2,4-Dinitrophenol (DNP) poses serious health-risks to humans. The aims of this three-stage multidisciplinary project were, for the first time, to assess the risks to the general public from fraudulent sale of or adulteration/contamination with DNP; and to investigate motives, reasons and risk-management among DNP-user bodybuilders and avid exercisers.

methodsUsing multiple search-engines and guidance for Internet research, online retailers and bodybuilding forums/blogs were systematically explored for availability of DNP, advice offered on DNP use and user profiles. Ninety-eight pre-workout and weight-loss supplements were purchased and analysed for DNP using liquid-chromatography-mass-spectrometry. Psychosocial variables were captured in an international sample of 35 DNP users (26.06 ± 6.10 years, 94.3 % male) with an anonymous, semi-qualitative self-reported survey.

resultsAlthough an industrial chemical, evidence from the Internet showed that DNP is sold 'as is', in capsules or tablets to suit human consumption, and is used 'uncut'. Analytical results confirmed that DNP is not on the supplement market disguised under fictitious supplement names, but infrequently was present as contaminant in some supplements (14/98) at low concentration (<100mcg/kg). Users make conscious and 'informed' decisions about DNP; are well-prepared for the side-effects and show nonchalant attitude toward self-experimentation with DNP. Steps are often taken to ensure that DNP is genuine. Personal experience with performance- and appearance enhancing substances appears to be a gateway to DNP. Advice on DNP and experiences are shared online. The significant discrepancy between the normative perception and the actual visibility suggests that DNP use is-contrary to the Internet accounts-a highly concealed and lonesome activity in real life. Positive experiences with the expected weight-loss prevail over the negative experiences from side effects (all but two users considered using DNP again) and help with using DNP safely is considered preferable over scare-tactics.

conclusionLegislation banning DNP sale for human consumption protects the general public but DNP is sold 'as is' and used 'uncut' by determined users who are not dissuaded from experimenting with DNP based on health threats. Further research with stakeholders' active participation is imperative for targeted, proactive public health policies and harm-reduction measures for DNP, and other illicit supplements.

Indexed as

Health Knowledge, Attitudes, PracticeInternet2,4-DinitrophenolAdultAnti-Obesity AgentsAthletesCommerceDietary SupplementsDrug ContaminationFemaleHealth SurveysHumansMaleMotivationYoung Adult2,4-DinitrophenolAnti-Obesity Agents

Identifiers

PMID26466580
PMCPMC4607104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.